Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Reported Tuberculosis in the United States, 2013

Return to Main Menu

(PDF - 191k)

Table 50. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to INH or Multidrug Resistance: Reporting Areas, 2013

Reporting Area Total Culture Positive Cases Cases with Initial Drug-Susceptibility Testing Performed1 Resistance2
Isoniazid1 Isoniazid and Rifampin1
No. (%) No. (%) No. (%)
United States

7,358

7,108

(96.6)

653

(9.2)

95

(1.3)
 
Alabama 83 83 (100.0) 4 (4.8) 1 (1.2)
Alaska 55 54 (98.2) 5 (9.3) 0 (0.0)
Arizona 154 154 (100.0) 17 (11.0) 1 (0.6)
Arkansas 52 51 (98.1) 1 (2.0) 0 (0.0)
California 1,759 1,705 (96.9) 182 (10.7) 27 (1.6)
Colorado 48 48 (100.0) 2 (4.2) 0 (0.0)
Connecticut 51 47 (92.2) 7 (14.9) 1 (2.1)
Delaware 13 8 (61.5) --- --- --- ---)
District of Columbia 26 24 (92.3) 4 (16.7) 1 (4.2)
Florida 514 484 (94.2) 37 (7.6) 9 (1.9)
Georgia 235 229 (97.4) 23 (10.0) 2 (0.9)
Hawaii 92 90 (97.8) 11 (12.2) 0 (0.0)
Idaho 9 9 (100.0) 0 (0.0) 0 (0.0)
Illinois 240 232 (96.7) 24 (10.3) 3 (1.3)
Indiana 73 72 (98.6) 8 (11.1) 0 (0.0)
Iowa 32 31 (96.9) 2 (6.5) 1 (3.2)
Kansas 40 40 (100.0) 0 (0.0) 0 (0.0)
Kentucky 47 47 (100.0) 2 (4.3) 0 (0.0)
Louisiana 117 92 (78.6) 5 (5.4) 1 (1.1)
Maine 8 8 (100.0) 0 (0.0) 0 (0.0)
Maryland 123 123 (100.0) 13 (10.6) 2 (1.6)
Massachusetts 153 149 (97.4) 18 (12.1) 7 (4.7)
Michigan 98 94 (95.9) 3 (3.2) 0 (0.0)
Minnesota 116 113 (97.4) 13 (11.5) 0 (0.0)
Mississippi 49 47 (95.9) 1 (2.1) 0 (0.0)
Missouri 72 72 (100.0) 6 (8.3) 0 (0.0)
 
Montana 6 6 (100.0) 1 (16.7) 0 (0.0)
Nebraska 14 14 (100.0) 0 (0.0) 0 (0.0)
Nevada 63 59 (93.7) 5 (8.5) 0 (0.0)
New Hampshire 15 14 (93.3) 2 14.3 0 (0.0)
New Jersey 256 253 (98.8) 29 (11.5) 5 (2.0)
New Mexico 39 39 (100.0) 5 (12.8) 1 (2.6)
New York State3 157 155 (98.7) 7 (4.5) 1 (0.6)
New York City 472 455 (96.4) 47 (10.3) 7 (1.5)
North Carolina 164 161 (98.2) 13 (8.1) 5 (3.1)
North Dakota 6 0 (0.0) -- -- -- --
Ohio 119 119 (100.0) 6 (5.0) 3 (2.5)
Oklahoma 49 44 (89.8) 2 (4.5) 0 (0.0)
Oregon 55 55 (100.0) 2 (3.6) 1 (1.8)
Pennsylvania 168 157 (93.5) 13 (8.3) 3 (1.9)
Rhode Island 13 13 (100.0) 0 (0.0) 0 (0.0)
South Carolina 79 76 (96.2) 5 (6.6) 0 (0.0)
South Dakota 6 5 (83.3) 0 (0.0) 0 (0.0)
Tennessee 102 99 (97.1) 6 (6.1) 1 (1.0)
Texas 921 894 (97.1) 61 (6.8) 5 (0.6)
Utah 24 24 (100.0) 0 (0.0) 0 (0.0)
Vermont 3 3 (100.0) 1 (33.3) 1 (33.3)
Virginia 139 135 (97.1) 16 (11.9) 1 (0.7)
Washington 177 174 (98.3) 22 (12.6) 2 (1.1)
West Virginia 12 12 (100.0) 3 (25.0) 0 (0.0)
Wisconsin 44 44 (100.0) 15 (34.1) 3 (0.0)
Wyoming 0 0 --- 0 --- 0 ---
 
American Samoa4 2 1 (50.0) --- --- --- ---
Fed. States of Micronesia4 57 40 (70.2) -- -- -- --
Guam4 25 25 (100.0) 3 (12.0) 0 (0.0)
Marshall Islandsv 64 58 (90.6) 2 (3.4) 1 (1.7)
N. Mariana Islands4 15 10 (66.7) --- --- --- ---
Puerto Rico4 45 43 (95.6) 4 (9.3) 1 (2.3)
Republic of Palauv 6 0 (0.0) -- -- -- --
U.S. Virgin Islands4 2 1 (50.0) -- -- -- --

1 Patients tested to at least isoniazid and rifampin

2 Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages shown only for reporting areas with information reported for ≥75% of cases.

3 Excludes New York City.

4 Not included in U.S. totals.

Note: Ellipses indicate data not available.

Top